PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition

Epithelial-mesenchymal transition (EMT) has an established role in the acquisition of therapeutic resistance. Programmed cell death domain 2 (PDCD2) is involved in the progression of multiple types of cancer. However, its mechanism underlying chemoresistance in liver cancer has not been elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongyu, Wang, Min, Liang, Na, Guan, Lianyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390009/
https://www.ncbi.nlm.nih.gov/pubmed/30664177
http://dx.doi.org/10.3892/mmr.2019.9860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390009/
https://www.ncbi.nlm.nih.gov/pubmed/30664177
http://dx.doi.org/10.3892/mmr.2019.9860

Ejemplares similares